 0 Table of Contents |
  1 Home |
  2 2016 CDC Guideline - Profiles |
  3 2016 CDC Guideline - Terminology |
  4 2016 CDC Guideline - Examples |
  5 2016 CDC Guideline - Documentation |
   5.1 2016 CDC Guideline - Implementation Documentation |
   5.2 2016 CDC Guideline - Integration Documentation |
   5.3 2016 CDC Guideline - Process Documentation |
   5.4 2016 CDC Guideline - Service Documentation |
  6 2016 CDC Guideline - Downloads |
  7 2016 CDC Guideline - Quick Start |
  8 Conformance Resource Registry |
  9 Chronic Pain Decision Documentation |
  10 2016 CDC Guideline Recommendation #1 - Nonpharmacologic and Nonopioid Pharmacologic Therapy Consideration |
   10.1 OpioidCDS Recommendation 01 - CQL Source |
  11 2016 CDC Guideline Recommendation #2 - Opioid Therapy Goals Discussion |
   11.1 OpioidCDS Recommendation 02 - CQL Source |
  12 2016 CDC Guideline Recommendation #3 - Opioid Therapy Risk/Benefit Discussion |
   12.1 OpioidCDS Recommendation 03 - CQL Source |
  13 2016 CDC Guideline Recommendation #4 Order Sign Variation - Opioid Immediate Release Form When Starting Opioid Therapy |
   13.1 OpioidCDS Recommendation 04 Order Sign - CQL Source |
  14 2016 CDC Guideline Recommendation #4 Patient View Variation - Opioid Immediate Release Form When Starting Opioid Therapy |
   14.1 OpioidCDS Recommendation 04 Patient View - CQL Source |
  15 2016 CDC Guideline Recommendation #5 - Lowest Effective Dose |
   15.1 OpioidCDS Recommendation 05 - CQL Source |
  16 2016 CDC Guideline Recommendation #6 - Prescribe Lowest Effective Dose and Duration |
   16.1 OpioidCDS Recommendation 06 - CQL Source |
  17 2016 CDC Guideline Recommendation #7 - Opioid Therapy Risk Assessment |
   17.1 2016 CDC Guideline OpioidCDS Recommendation 07 - CQL Source |
  18 2016 CDC Guideline Recommendation #8 - Naloxone Consideration |
   18.1 OpioidCDS Recommendation 08 - CQL Source |
  19 2016 CDC Guideline Recommendation #9 - Consider Patient's History of Controlled Substance Prescriptions |
   19.1 OpioidCDS Recommendation 09 - CQL Source |
  20 2016 CDC Guideline Recommendation #10 Order Sign Variation - Urine Drug Testing |
   20.1 OpioidCDS Recommendation 10 Order Sign - CQL Source |
  21 2016 CDC Guideline Recommendation #10 Patient View Variation - Urine Drug Testing |
   21.1 OpioidCDS Recommendation 10 Patient View - CQL Source |
  22 2016 CDC Guideline Recommendation #11 Order Select Variation - Concurrent Use of Opioids and Benzodiazepines |
   22.1 OpioidCDS Recommendation 11 Order Select - CQL Source |
  23 2016 CDC Guideline Recommendation #11 Patient View Variation - Concurrent Use of Opioids and Benzodiazepines |
   23.1 OpioidCDS Recommendation 11 Patient View - CQL Source |
  24 2016 CDC Guideline Recommendation #12 - Evidence-based Treatment for Patients with Opioid Use Disorder |
   24.1 OpioidCDS Recommendation 12 (patient-view) - CQL Source |
  25 License and Legal Terms |
  26 Artifacts Summary |
   26.1 HelloWorld |
   26.2 HelloWorldPatientView |
   26.3 CDCMMEClinicalConversionFactors |
   26.4 OpioidCDSRoutines |
   26.5 OpioidCDSCommon |
   26.6 OpioidCDSCommonConfig |
   26.7 OpioidLogicMK2020 |
   26.8 OpioidData2020 |
   26.9 OpioidLogicMK2019 |
   26.10 OpioidData2019 |
   26.11 FHIRHelpers |
   26.12 FHIRModelInfo |
   26.13 OpioidCDSREC10CommonLibrary |
   26.14 OpioidCDSREC01Library |
   26.15 OpioidCDSREC01Library |
   26.16 OpioidCDSREC03Library |
   26.17 OpioidCDSREC04Library |
   26.18 OpioidCDSREC04PatientViewLibrary |
   26.19 OpioidCDSREC05Library |
   26.20 OpioidCDSREC06Library |
   26.21 OpioidCDSREC07Library |
   26.22 OpioidCDSREC08Library |
   26.23 OpioidCDSREC09Library |
   26.24 OpioidCDSREC10Library |
   26.25 OpioidCDSREC10PatientViewLibrary |
   26.26 OpioidCDSREC11Library |
   26.27 OpioidCDSREC11PatientViewLibrary |
   26.28 OpioidCDSREC12PatientViewLibrary |
   26.29 OpioidRiskAssessmentActivityDefinition |
   26.30 OpioidUrineScreeningActivityDefinition |
   26.31 PlanDefinition - CDC 2016 Opioid Prescribing Guideline Recommendation #1 |
    26.31.1 Library |
   26.32 PlanDefinition - CDC 2016 Opioid Prescribing Guideline Recommendation #2 |
    26.32.1 Library |
   26.33 PlanDefinition - CDC 2016 Opioid Prescribing Guideline Recommendation #3 |
    26.33.1 Library |
   26.34 PlanDefinition - CDC 2016 Opioid Prescribing Guideline Recommendation #4 (patient view) |
    26.34.1 Library |
   26.35 PlanDefinition - CDC 2016 Opioid Prescribing Guideline Recommendation #4 |
    26.35.1 Library |
   26.36 PlanDefinition - CDC 2016 Opioid Prescribing Guideline Recommendation #5 |
    26.36.1 Library |
   26.37 PlanDefinition - CDC 2016 Opioid Prescribing Guideline Recommendation #6 |
    26.37.1 Library |
   26.38 PlanDefinition - CDC 2016 Opioid Prescribing Guideline Recommendation #7 |
    26.38.1 Library |
   26.39 PlanDefinition - CDC 2016 Opioid Prescribing Guideline Recommendation #8 (order-sign) |
    26.39.1 Library |
   26.40 PlanDefinition - CDC 2016 Opioid Prescribing Guideline Recommendation #8 |
    26.40.1 Library |
   26.41 PlanDefinition - CDC 2016 Opioid Prescribing Guideline Recommendation #9 |
    26.41.1 Library |
   26.42 PlanDefinition - CDC 2016 Opioid Prescribing Guideline Recommendation #10 (order-sign) |
    26.42.1 Library |
   26.43 PlanDefinition - CDC 2016 Opioid Prescribing Guideline Recommendation #10 (patient-view) |
    26.43.1 Library |
   26.44 PlanDefinition - CDC 2016 Opioid Prescribing Guideline Recommendation #10 |
    26.44.1 Library |
   26.45 PlanDefinition - CDC 2016 Opioid Prescribing Guideline Recommendation #11 (patient-view) |
    26.45.1 Library |
   26.46 PlanDefinition - CDC 2016 Opioid Prescribing Guideline Recommendation #11 |
    26.46.1 Library |
   26.47 PlanDefinition - CDC 2016 Opioid Prescribing Guideline Recommendation #12 (patient-view) |
    26.47.1 Library |
   26.48 Morphine Milligram Equivalent (MME) Conversion Factors for FHIR R4 |
   26.49 Morphine Milligram Equivalent (MME) Calculator for FHIR R4 |
   26.50 Opioid Management Terminology Knowledge Data |
   26.51 Opioid Management Terminology Knowledge Logic |
   26.52 CDC_CarePlan |
   26.53 CDC_MedicationRequest |
   26.54 CDC_Observation |
   26.55 CDC_RequestGroup |
   26.56 CDC-ValueSet |
   26.57 DataDateRollerExtension |
   26.58 OpioidCDSIndicator |
   26.59 CDC 2016 Opioid Guidance Clinical Focus Extension |
   26.60 CDC 2016 Opioid Guidance Data Element Extension |
   26.61 CDC 2016 Opioid Guidance exclusion Criteria Extension |
   26.62 CDC 2016 Opioid Guidance Inclusion Criteria Extension |
   26.63 Action_indicator |
   26.64 benzodiazepine medications |
   26.65 Buprenorphine and Methadone medications |
   26.66 CDC malignant cancer conditions |
   26.67 Cocaine urine drug screening tests |
   26.68 ValueSet - Condition Clinical Status Active |
   26.69 ValueSet - Encounter Diagnosis Condition Categories |
   26.70 ValueSet - Problem List Condition Category |
   26.71 ValueSet - US Core Health Concern Condition Category |
   26.72 Conditions documenting substance misuse |
   26.73 Conditions likely terminal for opioid prescribing |
   26.74 Extended release opioid with ambulatory misuse potential |
   26.75 Fentanyl-type medications |
   26.76 Fentanyl-type urine drug screening tests |
   26.77 General opiate urine drug screening tests |
   26.78 ValueSet - Hospice Disposition |
   26.79 Hospice Finding |
   26.80 Hospice Procedure |
   26.81 Limited life expectancy conditions |
   26.82 ValueSet - Medication Request Category Community |
   26.83 ValueSet - Medication Request Status Active |
   26.84 naloxone medications |
   26.85 Non-opioid drug urine screening |
   26.86 Non-synthetic opioid medications |
   26.87 ValueSet - Observation Category Laboratory |
   26.88 ValueSet - Observation Category Procedure |
   26.89 ValueSet - Office Visit |
   26.90 Oncology specialty designations (NUCC) |
   26.91 Opiate specific urine drug screening tests |
   26.92 Opioid analgesics with ambulatory misuse potential |
   26.93 Opioid counseling procedure |
   26.94 Opioid drug urine screening |
   26.95 Opioid misuse assessment procedure |
   26.96 Opioid misuse disorders |
   26.97 ValueSet - Opioid Indicator |
   26.98 Pain management procedure |
   26.99 Pain treatment plan |
   26.100 PDMP data reviewed finding |
   26.101 PDMP review procedure |
   26.102 Phencyclidine urine drug screening tests |
   26.103 Substance misuse behavioral counseling |
   26.104 Synthetic opioid urine drug screening tests |
   26.105 Therapies indicating end of life care |
   26.106 Urine drug screening tests |
   26.107 CodeSystem - CDC 2016 Opioid Indicator |
   26.108 OpioidCDS CarePlan |
   26.109 Cancer Diagnosis Condition |
   26.110 End of Life Condition |
   26.111 Terminal Condition |
   26.112 Cancer Diagnosis Encounter |
   26.113 Oncology Participant Encounter |
   26.114 Recommendation 10 Patient View Context Encounter Example |
   26.115 Recommendation 10 Patient View Prefetch Encounter Example |
   26.116 Ambulatory Opioid MedicationDispense |
   26.117 OpioidCDS MedicationRequest |
   26.118 Ambulatory Opioid MedicationRequest |
   26.119 Recommendation 10 Patient View Context MedicationRequest Example |
   26.120 Recommendation 10 Patient View Prefetch MedicationRequest Example |
   26.121 OpioidCDS Observation |
   26.122 OpioidCDS Patient |
   26.123 Recommendation 10 Patient View Prefetch Patient Example |
   26.124 Oncology Specialist PractitionerRole |
   26.125 OpioidCDS RequestGroup |
   26.126 Palliative Care ServiceRequest |
   26.127 CQFToolingDevice |